Additional file 2: Table S1. of Rho-associated protein kinase 2 (ROCK2): a new target of autoimmunity in paraneoplastic encephalitis
Stoyan Popkirov(University of Duisburg-Essen), Ingo Kleiter(Dentsply Sirona (United States)), Sebastian Berg(Universitätsklinik Marien Hospital Herne), Joachim Noldus(Universitätsklinik Marien Hospital Herne), Christiane Radzimski(Euroimmun Medizinische Labordiagnostika (Germany)), Christos Krogias(St. Josef-Hospital), Nicole Rieckhoff(Euroimmun Medizinische Labordiagnostika (Germany)), Lars Komorowski(Euroimmun Medizinische Labordiagnostika (Germany)), Uwe Schlegel(Defence Research and Development Organisation), Volkmar Hans(Evangelisches Krankenhaus Bielefeld), Ramona Miske(Euroimmun Medizinische Labordiagnostika (Germany)), Sabine Skodda(Universitätsklinikum Knappschaftskrankenhaus Bochum), Yvonne Denno(Euroimmun Medizinische Labordiagnostika (Germany)), Jan S. Bauer(TUM Klinikum), Ralf Gold, Christian Probst, Winfried StĂścker, Ilya Ayzenberg, Christian Bien, Stefanie Hahn(Euroimmun Medizinische Labordiagnostika (Germany)), JĂśrg Wellmer, Florian Roghmann(Universitätsklinik Marien Hospital Herne)
Cited by 0
Related Papers
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
|Journal of Neuroinflammation|2016|896
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
|Journal of Neurology|2013|604
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518